Get access

Opsoclonus Myoclonus Syndrome associated with GQ1b Antibodies

Authors

  • Hugo Morales-Briceño MD,

    1. Department of Neurology, Instituto Nacional de Neurología y Neurocirugía, Mexico City, México
    Search for more papers by this author
  • Mayela Rodríguez-Violante MD, MSc,

    1. Clinical Neurodegenerative Disease Research Unit, Instituto Nacional de Neurología y Neurocirugía, Mexico City, México
    2. Movement Disorders Clinic, Instituto Nacional de Neurología y Neurocirugía, Mexico City, México
    Search for more papers by this author
  • Amin Cervantes-Arriaga MD, MSc,

    1. Clinical Neurodegenerative Disease Research Unit, Instituto Nacional de Neurología y Neurocirugía, Mexico City, México
    2. Movement Disorders Clinic, Instituto Nacional de Neurología y Neurocirugía, Mexico City, México
    Search for more papers by this author
  • Sarosh R. Irani MD, DPhil,

    1. Nuffield Department of Clinical Neurosciences, West Wing, John Radcliffe Hospital, Oxford, United Kingdom
    Search for more papers by this author
  • Andrew J. Lees MD, FRCP,

    1. Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology, London, United Kingdom
    Search for more papers by this author
  • Laura Silveira-Moriyama MD, PhD

    Corresponding author
    1. Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology, London, United Kingdom
    2. Department of Neurology, University of Campinas, UNICAMP, Campinas, Brazil
    • Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology, London, 1 Wakefield street, WC1N 1PJ, London, UK
    Search for more papers by this author

  • Relevant conflicts of interest/financial disclosures: Nothing to report.

  • Full financial disclosures and author roles may be found in the online version of this article.

No abstract is available for this article.

Ancillary